Scpharmaceuticals Inc (SCPH) — Cash Flow-to-Debt Ratio
Scpharmaceuticals Inc (SCPH) has a Cash Flow-to-Debt Ratio of -0.16x as of June 2025, meaning its operating cash flow of $-16.11 Million could theoretically repay 0% of its total liabilities ($101.57 Million) in one year. See Scpharmaceuticals Inc (SCPH) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Scpharmaceuticals Inc Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Scpharmaceuticals Inc across 10 annual periods. Also explore Scpharmaceuticals Inc annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Scpharmaceuticals Inc (2015–2024)
Year-by-year debt coverage analysis for Scpharmaceuticals Inc. For market capitalisation and broader financial context, see SCPH stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.75x | $-70.54 Million | $94.20 Million | ▲ +27.6% |
| 2023 | -1.03x | $-59.24 Million | $57.26 Million | ▼ -54.9% |
| 2022 | -0.67x | $-34.58 Million | $51.76 Million | ▲ +44.5% |
| 2021 | -1.20x | $-27.15 Million | $22.57 Million | ▼ -16.8% |
| 2020 | -1.03x | $-27.69 Million | $26.88 Million | ▲ +12.3% |
| 2019 | -1.17x | $-30.44 Million | $25.92 Million | ▲ +38.8% |
| 2018 | -1.92x | $-28.81 Million | $15.01 Million | ▼ -35.8% |
| 2017 | -1.41x | $-22.68 Million | $16.05 Million | ▼ -602.6% |
| 2016 | -0.20x | $-15.46 Million | $76.85 Million | ▲ +58.1% |
| 2015 | -0.48x | $-9.64 Million | $20.09 Million | — |